Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

In this study, a survey in Norway and Sweden among adults with self-reported alopecia areata revealed a substantial economic burden with annual mean costs of €7,677 in Norway and €12,582 in Sweden, largely due to indirect costs from reduced productivity.

This source reports that four weeks of dupilumab treatment led to notable improvement in skin lesions, including multiple erythematous patches and papules on the face, back, and limbs.

In this case report, a 62-year-old woman with suspected discoid lupus erythematosus experienced worsening skin and hair symptoms despite treatment with topical corticosteroids, immunomodulatory therapy, and hydroxychloroquine, leading to her referral to a tertiary dermatology center.

In this study, cicatricial alopecias were classified by inflammatory cell type and the researchers highlighted that primary cicatricial alopecia's exact causes remain unknown, accounting for 6% of all hair diseases despite its unclear prevalence.

In this study, researchers reported that while systemic antibiotics are often chosen first for treating severe folliculitis decalvans, they have a high discontinuation rate, suggesting an urgent need for more effective immunomodulatory treatments.

Spontaneous hair regrowth in alopecia areata is possible but varies greatly among individuals.

Baricitinib can help improve hair loss and skin color issues in people with Down syndrome.

Intralesional corticosteroids may be more effective than cryotherapy for hair regrowth in alopecia areata.

In this study, a triple wavelength laser was found to be highly effective and well-tolerated for reducing hair in Indian women with Fitzpatrick skin types III and IV, achieving an average hair count reduction of 86.5%, with only mild and transient adverse effects observed.

This study observed no significant relationship between androgenetic alopecia and psychosocial or sexual symptoms among men aged 33 to 35 in the Northern Finland Birth Cohort 1986, challenging previous findings of such associations.

Low-dose Ritlecitinib may help children with stubborn Alopecia Areata.

The Paxbp1 gene is crucial for healthy hair follicles.

This study found that individuals with hospital-treated alopecia areata in Denmark had increased standardized incidence rates of serious infections, herpes zoster infections, lymphoma, cardiovascular events, and death compared to the age- and sex-matched general population.

Topical minoxidil may cause cherry hemangiomas in some users.

This review evaluates 21 studies on minoxidil-induced allergic contact dermatitis, finding that some patients with contact dermatitis symptoms like erythema and pruritus are sensitized to minoxidil or its vehicle components and should consider patch testing and alternative formulations for proper management.

In this real-world study, JAK inhibitors like abrocitinib and tofacitinib led to substantial hair regrowth in 61% of alopecia areata patients over a median of 16 months, with 75% of non-responders achieving regrowth after switching medications; however, two serious adverse events were noted.

This cross-sectional survey found that individuals with alopecia areata and androgenetic alopecia perceived stigmatization and impaired quality of life, with greater stigma reported in German-speaking participants; factors like gender, age, and disease severity influenced stigmatization levels.

In this study, infants born to mothers with alopecia areata had a higher risk of adverse birth outcomes, including preterm birth, low birth weight, Caesarean section, and congenital malformations.

This review discusses the promising role of JAK inhibitors in managing alopecia areata, reporting significant hair regrowth and acceptable safety profiles but noting the need for further research on dosing and long-term safety.

In this study, oral minoxidil treatment significantly increased serum VEGF levels and improved hair growth measures compared to a control group, suggesting its potential as an effective approach for promoting hair regrowth in androgenetic alopecia.

This study in a real-world setting found that baricitinib was effectively reducing disease severity in severe alopecia areata patients over 52 weeks, with 37.20% of participants achieving significant improvement and 72.40% experiencing mild or no adverse events.

This study found a high prevalence of alopecia in adolescents from northern Sudan, especially among females, and identified iron deficiency as significantly associated with the condition.

In this case report, a patient developed facial zona zoster as an unexpected complication following cryotherapy, adding to the list of known adverse effects such as dyspigmentation, scar formation, and hair loss.

This case report describes radiation-induced alopecia in a patient following a fluoroscopy-guided procedure, with complete hair regrowth after six months of topical minoxidil treatment.

This study reported a case of equine ringworm infection in a 2-year-old horse caused by Nannizzia gypsea, confirmed through culture and SYBR-Green real-time PCR techniques, demonstrating that qPCR allows specific detection of dermatophytes more rapidly than conventional methods.

Topical minoxidil effectively stimulates hair growth in men with hair loss.

This study reports that folliculitis decalvans and lichen planopilaris phenotypic spectrum is an underdiagnosed form of cicatricial alopecia, potentially treatable with anti-inflammatory drugs used for lichen planopilaris.

This case report documents the first known occurrence of an epidermoid cyst in the mammary gland of a 12-year-old female dog. The study emphasizes its benign nature but notes the potential for misdiagnosis and importance for pathologists to consider it during examinations.